Maple Capital Management’s Idexx Laboratories IDXX Stock Holding History

Maple Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$264K	Sell	469 -64	-12%	-$41K	0.02%	100
2025 Q4	$361K	Buy	533 +4	+0.8%	+$2.72K	0.02%	91
2025 Q3	$338K	Sell	529 -39	-7%	-$23.7K	0.02%	91
2025 Q2	$305K	Sell	568 -5	-0.9%	-$2.39K	0.02%	95
2025 Q1	$241K	Buy	573 +5	+0.9%	+$2.17K	0.02%	109
2024 Q4	$235K	Hold	568	–	–	0.02%	101
2024 Q3	$287K	Hold	568	–	–	0.02%	98
2024 Q2	$277K	Sell	568 -37	-6%	-$18.6K	0.02%	102
2024 Q1	$327K	Hold	605	–	–	0.03%	90
2023 Q4	$336K	Hold	605	–	–	0.03%	78
2023 Q3	$265K	Hold	605	–	–	0.03%	85
2023 Q2	$304K	Sell	605 -20	-3%	-$9.58K	0.03%	80
2023 Q1	$313K	Sell	625 -8	-1%	-$3.83K	0.04%	79
2022 Q4	$258K	Buy	633 +4	+0.6%	+$1.55K	0.03%	82
2022 Q3	$269K	Sell	629 -15	-2%	-$5.51K	0.03%	82
2022 Q2	$226K	Sell	644 -16	-2%	-$6.52K	0.03%	85
2022 Q1	$361K	Sell	660 -5	-0.8%	-$2.63K	0.04%	78
2021 Q4	$438K	Hold	665	–	–	0.05%	74
2021 Q3	$414K	Hold	665	–	–	0.05%	74
2021 Q2	$447K	Sell	665 -20	-3%	-$11K	0.05%	75
2021 Q1	$335K	Hold	685	–	–	0.05%	76
2020 Q4	$342K	Sell	685 -6	-0.9%	-$2.69K	0.05%	78
2020 Q3	$313K	Hold	691	–	–	0.05%	81
2020 Q2	$228K	Buy	+691	New	+$200K	0.04%	93
2019 Q3	–	Sell	-734	Closed	-$202K	–	123
2019 Q2	$202K	Buy	+734	New	+$181K	0.05%	120

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Maple Capital Management's IDXX Position: Q1 2026 in Review

Maple Capital Management reduced its Idexx Laboratories (IDXX) stake by 12% in Q1 2026, selling an estimated $41K and leaving 469 shares worth $264K. The position accounts for 0.02% of the portfolio, ranked #100.

Maple Capital Management first reported a position in IDXX in Q2 2019 and has held it in 25 quarters since. The position peaked at $447K in Q2 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Maple Capital Management held 469 shares of Idexx Laboratories worth $264K as of Q1 2026.
Maple Capital Management sold 64 Idexx Laboratories shares in Q1 2026, an estimated $41K.
Idexx Laboratories made up 0.02% of Maple Capital Management's portfolio in Q1 2026, its #100 holding.
Maple Capital Management first reported a position in Idexx Laboratories in Q2 2019 and has held it in 25 quarters since.
Maple Capital Management's Idexx Laboratories position peaked at $447K in Q2 2021.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Maple Capital Management's 13F filing for Q1 2026, filed 8 May 2026.